Home > Drug Search >
  • company_query: BioClin Therapeutics
  •   > 
Drug Filter
Category:
chemistry (7) biology (23)
Status:
Approved (2) NDA Filing (1) Phase Ⅲ (2) Phase Ⅱ (10) Phase Ⅰ (15)
Clinical Stage:
Pending (4) Active (20) Discontinued (4)
Bio-Type:
Cell therapy (1) CAR T cell therapy (1) Vaccine (7) Blood extraction (2) Whole antibody (7) Fab fragment (1) Fusion protein (1)
Indication:
Acute myeloid Leukemia (AML) (3) Anemia (1) Bladder cancer (1) Breast cancer (2) Cystic fibrosis (CF) (1) Transplant rejection (1) Hypovolemia (1) Influenza virus infection (4) Pseudomonal infection (1) Major depressive disorder (MDD) (1) Multiple myeloma (MM) (1) Myelodysplastic syndrome (MDS) (3) Non small cell lung cancer (NSCLC) (2) Obesity (2) Ovarian cancer (1) Pancreatic cancer (1) Pneumonia (1) Prostate cancer (1) Rheumatoid arthritis (RA) (2) Solid tumours (4) Nasopharyngeal cancer (1) Nosocomial Pneumonia (NP) (1) Diagnostic agents (1) Contraception (1) Sepsis (1) Mycosis fungoides (1) Staphylococcal infection (1) Respiratory syncytial virus infection (1) hematological malignancies (2) Ebola virus disease (EVD) (1) Human papillomavirus infections (HPV) (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top